We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$134M
(+6.1%)
Cap. Flow
+$20.8M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
3,655
New
192
Increased
1,156
Reduced
1,283
Closed
307
Avg Time Held Equity + Options
3.3
years
Top 10 Avg Time Held Equity + Options
2.3
years
Top 20 Avg Time Held Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$38.6M |
| 2 |
iShares International Select Dividend ETF
IDV
|
+$16.7M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$9.62M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$7.02M |
| 5 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$6.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$15.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$14.4M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$9.84M |
| 4 |
SPDR Gold Trust
GLD
|
+$8.28M |
| 5 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$7.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.63% |
| 2 | Technology | 11.72% |
| 3 | Healthcare | 8.76% |
| 4 | Financials | 8.75% |
| 5 | Consumer Discretionary | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
XXII
3251
22nd Century Group
XXII
$448K
| – | – |
0
| – | – |
2018 Q2
18 quarters
|
|
3252
DELISTED
Doma Holdings, Inc.
DOMA
| $45 | ﹤0.01% |
4
| – | – |
2021 Q3
5 quarters
|
|
3253
Tvardi Therapeutics
TVRD
$14.3M
| – | – |
0
| – | – |
2022 Q1
3 quarters
|
|
3254
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $39 | ﹤0.01% |
1
-6
| -86% | -$230 |
2022 Q2
2 quarters
|
|
3255
KALA BIO
KALA
$3.72M
| – | – |
0
| – | – |
2021 Q1
7 quarters
|
|
3256
Hyliion Holdings
HYLN
$586M
| $33 | ﹤0.01% |
14
-20
| -59% | -$54 |
2020 Q3
9 quarters
|
|
|
TSP
3257
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $33 | ﹤0.01% |
20
-29
| -59% | -$103 |
2022 Q2
2 quarters
|
|
3258
Solid Biosciences
SLDB
$615M
| $32 | ﹤0.01% |
6
-1
| -14% | -$7 |
2022 Q1
3 quarters
|
|
3259
DELISTED
2seventy bio
TSVT
| $28 | ﹤0.01% |
3
| – | – |
2022 Q1
3 quarters
|
|
3260
Ambow Education Holding
AMBO
$4.81M
| $27 | ﹤0.01% |
+9
| New | +$28 |
2022 Q4
0 quarters
|
|
3261
Corbus Pharmaceuticals
CRBP
$83.7M
| $22 | ﹤0.01% |
+7
| New | +$27 |
2022 Q4
0 quarters
|
|
3262
DELISTED
Potbelly
PBPB
| $22 | ﹤0.01% |
4
| – | – |
2021 Q2
6 quarters
|
|
3263
Rigetti Computing
RGTI
$4.22B
| $22 | ﹤0.01% |
30
| – | – |
2021 Q4
4 quarters
|
|
3264
DELISTED
Rubicon Technologies, Inc.
RBT
| $21 | ﹤0.01% |
2
| – | – |
2022 Q3
1 quarter
|
|
3265
AiRWA Inc
YYAI
$3.45M
| – | – |
0
| – | – |
2022 Q3
1 quarter
|
|
3266
Corvus Pharmaceuticals
CRVS
$829M
| $17 | ﹤0.01% |
20
| – | – |
2021 Q2
6 quarters
|
|
3267
Ellsworth Growth & Income Fund
ECF
$161M
| $16 | ﹤0.01% |
2
-127
| -98% | -$1.06K |
2021 Q1
7 quarters
|
|
3268
Goldgroup Mining
GORO
$563M
| $16 | ﹤0.01% |
3
| – | – |
2021 Q3
5 quarters
|
|
3269
Cenntro
CENN
$7.74M
| – | – |
0
| – | – |
2021 Q2
6 quarters
|
|
3270
OmniAb
OABI
$688M
| $14 | ﹤0.01% |
+4
| New | +$21 |
2022 Q4
0 quarters
|
|
3271
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $12 | ﹤0.01% |
8
| – | – |
2018 Q4
16 quarters
|
|
3272
DELISTED
Vertex Energy, Inc
VTNR
| $12 | ﹤0.01% |
2
| – | – |
2022 Q2
2 quarters
|
|
3273
Western Copper and Gold
WRN
$414M
| $11 | ﹤0.01% |
6
| – | – |
2016 Q4
24 quarters
|
|
3274
Bionano Genomics
BNGO
$16.1M
| – | – |
0
| – | – |
2022 Q1
3 quarters
|
|
|
BLCM
3275
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $7 | ﹤0.01% |
10
| – | – |
2020 Q2
10 quarters
|
|
Similar funds
Parallel Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Parallel Advisors held 3,655 positions worth $2.31B, up 6.1% from $2.17B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2022 filing shows 192 new, 1,156 increased, 1,283 reduced and 307 closed positions. Its largest new stake was US Treasury 2 Year Note ETF: 9,020 shares worth $440K. The largest sale was iShares Core MSCI EAFE ETF, an estimated $15.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q4 2022 buy was US Treasury 2 Year Note ETF: 9,020 shares worth $440K.
- Parallel Advisors added most to Schwab US Dividend Equity ETF in Q4 2022, an estimated $38.6M increase.
- Parallel Advisors's biggest Q4 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $15.8M.
- Parallel Advisors fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.3M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.31B portfolio in Q4 2022.
- Parallel Advisors opened 192 new positions and closed 307 in Q4 2022.
- Parallel Advisors's portfolio value rose 6.1% quarter-over-quarter to $2.31B.
Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.